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In this study we report the isolation and characterization of three overlapping cDNA clones for the type I/3 isozyme of 
cGMP-dependent protein kinase (cGK) from human placenta libraries. The composite sequence was 3740 nucleotides 
long and contained 58 nucleotides from the S-noncoding region, an open reading frame of 2061 bases including the stop 
codon, and a 3’noncoding region of 1621 nucleotides. The predicted full-length human type IB cGK protein contained 
686 amino acids including the imtiator me~o~ne, and had an estimated molecular mass of 77 803 Da. On comparison 
to the published amino acid sequence of bovine lung Ia, human placenta I/I cGK differed by only two amino acids in 
the carboxyl-terminal region (amino acids 105686). In contrast, the amino-terminal region of the two proteins was mark- 
edly different (only 36% similarity), and human I/I cGK was 16 amino acids longer. In a specific region in the amino- 
terminus (amino acids 6375) 12 out of 13 amino acids of the human I/f cGK were identical to the partial amino acid 
sequence recently published for a new I/l isoform of cGK from bovine aorta. Northern blot analysis demonstrated a
human I/l cGK mRNA, 7 kb in size, in human uterus and weakly in placenta. An mRNA of 7 kb was also observed 
in rat cerebellum, cerebrum, lung, kidney, and adrenal, whereas an mRNA doublet of 7.5 and 6.5 kb were observed in 
rat heart. Comparison of Northern and Western blot analyses demon~rat~ that the mRNA and protein for cerebellar 
cGK increased uring the development of rats from 5 to 30 days old, whereas the 6.5 kb mRNA in rat heart declined. 
Protein kinase; cGMP-dependent; Molecular cloning; cDNA sequence; Tissue specific expression; (Human placenta) 
1. INTRODUCTION 
cGK is one of the major receptor proteins for 
cGMP in addition to certain forms of cyclic 
nucleotide phosphodiesterases and ion channels 
Correspondence address: M. Sandberg, Laboratory for Gene 
Technology, Institute of Pathology, Rikshospitalet, N-0027 
Oslo I, Norway 
The nucleotide sequence presented here has been submitted to 
the EMBL/GenBank database under the accession no.YO7512 
[ 1-43. Cyclic GMP and cGK play important roles 
in physiological processes such as relaxation of 
vascular smooth muscle and inhibition of platelet 
aggregation [5,6]. In addition, atrial natriuretic 
factor (ANF) may achieve its hemodynamic effects 
via activation of cGK [6,7]. 
Structurally, the most extensively studied form 
of cGK has been that from bovine lung [S]. 
However, significant amounts of cGK have been 
found in smooth muscle [6,9], in epithelial cells 
[lo], in platelets [I 11, and in rat cerebellar Purkinje 
cells [ 121. The native bovine lung enzyme is a 
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homodimer I&13,14]. Each of the subunits has a 
catalytic domain in the carboxyl-terminal region 
and a dimerization domain near the amino- 
terminus. Each subunit also has an inhibitory do- 
main for the catalytic moiety and two different 
cGMP-binding sites in the regulatory component 
located in the midportion of the peptide. Amino 
acid sequencing of the bovine lung enzyme has 
shown that it contains 670 amino acids and has a 
subunit M, of 76 33 1. Binding of cGMP to the pro- 
tein effects a conformational change resulting in 
activation of the enzyme. 
PAGE Mr = 78000 and 80000, respectively. Par- 
tial amino acid sequence analysis of type I,@ show- 
ed that it was clearly different from the type Icu 
isozyme in the amino-terminal region of the 
protein. 
No cDNA or genes for cGK from mamm~ian 
cells have previously been cloned. Recently, 
however, the isolation and ch~acterization of 
several cDNA and genomic clones for cGK from 
Drosophila have been described [ 18,191, 
As has been the case for several other enzymes, 
including the CAMP-dependent protein kinase, the 
cGK has been shown to be a family of closely 
related enzymes. Two main forms of cGK, a solu- 
ble form designated type I [8,15,16], and an intrin- 
sic membrane-bound form designated type II 1171, 
have been identified. Recent data from bovine aor- 
ta smooth muscle have shown the existence of two 
different isozyme forms of soluble type I cGK, 
designated types Icu and I@ [16]. The type ICY was 
shown to be similar to the well characterized 
bovine lung cGK, while type I/? was shown to be a 
novel form of cGK. Types Icr and I@ had SDS- 
In this manuscript we demonstrate the isolation 
and characterization of three human cDNA clones 
that encode a full-length cGK with amino acid se- 
quence similarities to the bovine type I,f? isozyme. 
Furthermore, we report the tissue distribution and 
developmental changes of cGK mRNA and protein 
levels in rat. 
2. MATERIALS AND METHODS 
2.1. Construction of cDNA libraries 
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A total of three different human placenta cDNA libraries in 
hgtll were screened: (if a library constructed as described by 
Gubler and Hoffman [ZO] using oligo-dT as primer (generous 
gift from Dr Tanya Z. Schulz, Department of Cell Biology, 
Bayfor College of Medicine, Texas Medical Center, Houston, 
TX); (ii) an ohgo dT-primed library from Clontech, Palo Alto, 
CA (Cat.no.HL 1008b); and (iii) a library, custom made by 
Clontech, using specific and random priming. 
2.2. Probe 
clone1 
> Claw2 
clone3 
The probe used to screen library no.1 was a 684 bp EcoRl 
fragment from a Drosophila cDNA for cGK (DG2, TIa) [19]. 
This Drosophila cGK fragment, located between nucleotides 
F841 and FL592 in the Drosophila cGK gene [19], gives rise to 
an amino acid sequence 74% similar to the ATP-binding and 
catalytic regions of bovine type Icu cGK (amino acids 351-578). 
The Drosophila probe was radioactively labeled by nick- 
translation. 
2.3. cDNA screening 
Fig. 1. Restriction map of human placenta cGK type W cDNA. 
Restriction sites are indicated at approximate positions within 
the composite map. Clones 1, 2 and 3 have been positioned to 
align identical regions. Hatched bars indicate reading frames, 
while the black box in clone 2 indicates the 115 nucleotide 
segment which gave rise to an amino acid sequence with no 
significant similarity to the bovine type Ia cGK (see text). 
Low stringency screening was performed using a protocol 
based on that of Rijsewijk et al. [Zl], and high stringency 
screening was performed as described by Sandberg et al. [22]. 
2.4. Subcloning and sequencing of DNA fragments 
Clones were isolated and digested with various restriction en- 
zymes, ligated into the vector Ml3 and sequenced by the 
September 1989 
Fig.2. Nucleotide and deduced amino acid sequence of human placenta cGK. Nucleotides are numbered starting with 1 at the first 
nucleotide in the coding region. Amino acids are shown in the three letter code. The stars indicate the first amino acid in the part 
of the sequence that is common to both Icu and I,& cGK. The first underlined amino acid (63) differs from that of the publish~ bovine 
I/3 cGK, while the second (280) and third (290) underIined amino acids represent he two differences between human I,?? and bovine 
Icu cGK between amino acids 105 and 686. 
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dideoxy chain-termination method of Sanger et al. [23]. All 
regions of the clones were sequenced at least twice. The region 
between nucleotides 124 and 246 in the composite sequence was 
difficult to resolve due to GC compressions using ordinary con- 
ditions. Therefore, the sequence in this area was verified by 
automatic sequencing performed by Lark Sequencing 
Technologies Ltd (Texas Medical Center, 1709 Dryden, Suite 
604, Houston, TX). Nucleotide and amino acid sequence data 
were analysed using the UWGCG program package [24]. 
2.5. RNA ~tract~on/Nort~e~n blot analysis 
RNA extraction and Northern blots of human tissues were 
performed as described earlier [25,26]. A 2.2 kb nick-tr~siated 
cGK cDNA (HindIII/EcoRI fragment, corresponding to 
nucleotides 1454-3682 in the composite sequence) and a 0.2 kb 
5 ’ EcoRI/PstI fragment (corresponding to nucleotides - 58 to 
129 in the composite sequence) were used for hybridization. For 
rat tissues, a LiCl-urea method was used to extract RNA [27], 
and Northern blots were hybridized with a “P-labeled com- 
plementary RNA made by in vitro transcription from a 
Bluescript plasmid containing the 50 nucleotide HindIII/KpnI 
human cGK cDNA insert (corresponding to nucleotides 
1454-1937 in the composite sequence) [28]. 
ed to nucleotides 936-2058 in the composite se- 
quence (fig.2) and gave rise to a sequence 374 
amino acids long. This sequence showed 100% 
similarity to amino acids 297-670 of the bovine 
type Ia cGK. The most 5 ’ 115 nucleotides of the 
isolated insert, however, gave rise to an amino acid 
sequence that showed no significant similarity to 
type Ia cGK (data not shown). No typical exon/in- 
tron junction was found to indicate that these 115 
nucleotides represented an intron from an un- 
processed mRNA [30]. 
2.6. Western blot analysis 
Rat (Sprague-Dawley) tissue extracts were obtained from a 
100000 x g centrifugation of whole homogenates and were 
analysed by SDS-PAGE and Western blotting for cGK protein 
as previously described using a monospecific antibody for cGK 
and ‘251-Protein A 1291. 
3. RESULTS 
Clone 1 was subsequently digested with restric- 
tion enzymes to obtain a 3 ’ 1.8 kb HindIII/EcoRI 
fragment (corresponding to nucleotides 1454-3269 
in the composite sequence) which was labeled and 
used to screen another human placenta cDNA 
library (library no.2) under high stringency 
hybridization conditions. From this screening, two 
identical positive clones were identified and 
isolated (fig. 1, clone 2). An insert of 3313 
nucleotides was sequenced and shown to contain 
an open reading frame of 1692 nucleotides (in- 
cluding the stop codon TAA). This coding region 
gave rise to a sequence 563 amino acids long that 
was 99.5% similar to amino acids 108-670 of the 
bovine type Icu cGK. The insert also contained 1621 
nucleotides 3 ’ of the stop codon. 
3.1. Isolation and characterization of ONAs 
We have previously identified and affinity 
purified cGK protein from human placenta. Based 
on this information we decided to clone human 
cGK cDNA from this tissue using a 684 bp EcoRI 
fragment of Drosophila cGK cDNA (see section 2) 
as a probe. The Drosophila probe was radioactive- 
ly labeled and used to screen a human placenta 
cDNA library (library no.1) under low stringency 
conditions. Two positive clones, later shown to be 
identical, were isolated. The inserts from the two 
positive clones were 2433 bp in length (fig. 1, clone 
1). Nucleotides 116-1238 of this insert correspond- 
In an effort to isolate the very 5 ‘-end of the 
cDNA, three specific oligonucleotides were design- 
ed which were complementary to nucleotides 
745-763, 1306-1324 and 2139-2157, respectively, 
in the composite sequence. These specific 
oligonucleotides, together with random 
oligonucleotides, were used as primers to construct 
another human placenta cDNA library (library 
no.3). This library was subsequently screened 
under high stringency conditions using the 5 ’ 
0.4 kb EcoRI-Hind111 fragment (corresponding to 
nucleotides 370-739 in the composite sequence) 
from clone 2 as a probe. One positive clone (fig. 1, 
clone 3) with a 0.8 kb insert was detected, isolated 
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human type I6 QSASTLQGEPRTKR-QAISAEP-TAFDIQDLStbfTLPFYPKSPQ ( 63-104) 
kwjm type IS E............ ( l- 13) 
krvine type Ia @vP~~HI*-.*-~-A~G **.**q*YRSFH**RQ-AFRKFL.*ER ( 47- 88) 
dmsophi la ATRKSG.NFQ*-QALG l - *- l -QSESSLL.E* l SF*K*D*DER (465-506) 
Fig.3. Sequence comparison between human type LB cGK, bovine type v, bovine type Ia and Drosophila DG2, TIa. Gaps, designated 
by dashes, are inserted to achieve maximal identity between the proteins. Dots represent identity with the human sequence. 
Autophosphorylated amino acids in the bovine type Iru sequence are underlined. 
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and characterized. Sequencing showed that it 
represented the 5 ’ -end of a type I cGK. In addition 
to 58 nucleotides 5 ’ of the start codon ATG, clone 
3 contained an open reading frame 751 nucleotides 
long. The deduced carboxyl-terminal 146 amino 
acids were identical to the bovine type Ia cGK 
(amino acids 89-234), but there were substantial 
differences between the deduced amino-terminal 
part of clone 3 and bovine type ICY cGK. Only 36% 
of the amino acids in this region (amino acids 
l-104) were identical to the bovine type ICZ cGK. 
However, 12 out of the 13 recently published 
amino acids from the bovine type I,8 were identical 
to amino acids 64-75 in the human sequence. 
The overlapping regions of clones 1 and 2 (2317 
nucleotides) and clones 2 and 3 (383 nucleotides) 
showed 100% nucleotide similarity making it very 
likely that these clones were derived from the same 
gene (fig.1). The composite sequence contained 
3740 nucleotides, with an open reading frame of 
2061 nucleotides giving rise to a 686 amino acid 
peptide (fig.2). In the amino acid region 105-686, 
the human type b3 cGK was identical to amino 
acids 89-670 of the bovine type Ia protein, with 
the exception of two amino acid substitutions. 
a 
c 
u) 
? 
fi 
al : 
a z 
Amino acids 280 (Thr) and 290 (Ser) in the human 
protein were replaced by Lys and Asn, respective- 
ly, in the bovine sequence. Both amino acid 
substitutions were located in the first cGMP- 
dependent binding region [8]. 
However, in the amino-terminal region of the 
molecules, there were substantial differences bet- 
ween human type I,JY cGK and bovine type Ia, 
although some areas showed sufficient similarity 
to indicate a common origin (fig.3). 
3.2. Determination of mRNA sizes and protein 
levels 
Northern analysis of the mRNA for human cGK 
(shown in fig.4A) detected a major 7 kb species in 
human uterus and placenta, although the signal in 
placenta was much weaker and not visible after 
photography. The same 7 kb message was iden- 
tified by two different labeled cDNA probes, either 
a 0.2 kb 5’ EcoRI/PstI fragment (data not shown) 
expected to be type Ip specific, or a 2.2 kb Hin- 
dIII/EcoRI fragment (fig.4A) expected to detect 
both type ICY and I,8 cGK mRNA. In uterus, a weak 
4.2 kb mRNA for cGK was also detected by both 
probes. Significant levels of cGK protein were 
4.2 kb - 
.>, *b :n :_ 
,:. 
‘( ‘ems* 
18s - 
A. Northern Blot B. Western Blot 
Fig.4. (A) Northern blot analysis for type I cGK in total RNA (20,~~) from human placenta and uterus. (B) Western blot analysis 
of the amount of cGK protein in human placenta and uterus (300~8 tissue extract each). A purified cGK standard (80 ng) is also 
shown. 
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Fig.5. Northern blot analysis of type 1 cGK mRNA in different tissues from rats at various days of age. Total RNA (10 cg each) was 
used for analysis. A “P-labeled RNA ladder used as a standard in determining cGK mRNA size is shown on the left. 
found in both uterus and placenta by Western blot 
analysis (fig.4B). 
In order to demonstrate further that the 7 kb 
mRNA showed other characteristics expected for 
cGK, Northern (fig.5) and Western (fig.6) analyses 
of several rat tissues were examined during 
postnatal development. Northern blots 
demonstrated a 7 kb mRNA in rat cerebellum and 
cerebrum, a 7.5 and 6.5 kb mRNA in rat heart, 
and no detectable mRNA in rat liver. The 7 kb 
mRNA was also found in rat lung, kidney, and 
adrenal (data not shown). Western blots showed 
that cGK protein was evident in all of these tissues, 
but that the amount expressed in liver was very lit- 
tle in comparison to the other tissues. This agreed 
with the Northern blots. 
A developmental increase in the amount of 
cerebellar cGK mRNA and protein was observed, 
in agreement with previous studies [3 11. A small in- 
crease in cerebrum cGK protein was not correlated 
with any increase in mRNA in cerebrum. The two 
heart mRNA forms, which differed from the 7 kb 
form in brain, showed different developmental 
declines, that for the 6.5 kb species being faster 
326 
and more complete (fig.5). This was not accom- 
panied by any obvious decrease in heart cGK pro- 
tein (fig.6). It is expected that the antibody used in 
the Western blots can recognize both Icu and I,0 
forms of cGK, since this was recently reported by 
Wolfe et al. [32], who used the same antibody in 
their studies. 
Repassage of total rat cerebellar RNA over a 
Pharmacia oligo-dT spin column caused a 7-fold 
enrichment of the major 7 kb mRNA and also 
minor mRNA forms of 4.2 and 2.5 kb (data not 
shown), indicating that the latter forms may also 
represent cGK mRNAs. The small band shown at 
1.7 kb in fig.5 did not appear to be enriched in the 
poly(A)+ RNA. 
4. DISCUSSION 
This report documents the isolation of cDNA 
clones encoding a full-length type I,8 cGK from 
human placenta. Molecular cloning of the human 
I,0 cGK was performed from placental tissue as a 
result of our previous knowledge that this tissue 
contained cGK protein. The fact that a total of ap- 
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Fig.6. Western blot analysis of cGK protein levels in different tissues (300 fig tissue extract each) of rats at various days of age. Purified 
cGK standards (100, 50, and 20 ng) are also shown. 
proximately three million clones from three dif- 
ferent placenta libraries were screened and only 
three different cDNA clones for cGK were obtain- 
ed, together with the low cGK mRNA signal in 
Northern analysis of placenta, indicates that the 
cGK message is rare in human placental tissue. 
The identity of the cDNA clones coding for the 
I@ form of the human cGK was verified by com- 
paring the deduced amino acid sequence to the 
recently published 13 amino acids for bovine type 
I,,3 [ 161. Twelve out of 13 amino acids reported for 
bovine I@ cGK, whereas only 6 out of 13 amino 
acids for the same area of bovine ILY showed identi- 
ty to the deduced amino acid sequence of human 
rp cGK (fig.3). The single amino acid difference 
(position 63, Gln in human and Glu in bovine) bet- 
ween bovine and human &3 cGK in this region may 
be due either to species differences or perhaps to a 
bovine cGK v Gln63-Glu deamidation conversion 
prior to amino acid sequencing. Furthermore, the 
molecular weight of bovine I@ cGK appeared 
greater than that of the Ia form on SDS-PAGE 
[15,32], which corresponds well with our observa- 
tion that human Ip is 16 amino acids longer than 
bovine Ia cGK. 
Comparison of the deduced amino acid se- 
quence of the isolated human type I,8 cGK to the 
known amino acid sequence for the bovine type Icr 
cGK showed that the carboxyl amino acids 
(105686) were 99.7% similar. Only 2 amino acid 
differences were seen in this region (bovine 10 cGK 
amino acids 264 (Lys) and 274 (Asn) correspond to 
human v cGK amino acids 280 (Thr) and 290 
(Ser), respectively). In contrast, the amino- 
terminal 104 amino acids of the bovine type Ia 
display only 36% similarity to the human type I/3 
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form. These data show that there is a clear change genes, or from a single gene either by alternative 
in similarity between the Icu and the Ip forms splicing or by use of different polyadenylation site 
beginning at amino acid 105. Changes like these signals. The latter mechanism is the one most com- 
typically indicate the involvement of mechanisms monly used for generating different mRNA species 
such as alternative splicing. The three nucleotides from genes for regulatory subunits of CAMP- 
preceding the codon giving rise to amino acid 105 dependent protein kinase [34]. None of the human 
are ‘CAG’, the most common nucleotides on the clones for I,& contained a poly(A) tail at the 3 ’ -end. 
5 ’ -exon of an exon/intron junction [30]. In Assuming that the 7 kb mRNA is derived from the 
Drosophila there is an exon/intron junction in the same gene as our human I,& cDNA clones, approx- 
cGK DG2 gene making amino acid 506 the last imately 3 kb of the 3 ’ -noncoding region is missing. 
amino acid coded by the first exon of the reading The availability of the present human Ip cGK 
frame. This amino acid corresponds to amino acid cDNAs encoding a full-length protein will allow 
104 in the human type I,& cGK and amino acid 88 further studies on the structure, function and 
in the bovine type Ia cGK, the last amino acids of regulation of cGKs in mammalian cells. Of special 
the ,&- and a-specific segments of the molecules, interest will be the use of the cDNAs for human I@ 
respectively (fig.3). These findings support the cGK to detect and study the gene(s) for cGK in an 
possibility that the ILY and I,& form of cGK are attempt to elucidate whether the Ia and I,& forms 
derived from the same gene by use of alternative are generated by alternative splicing. Such studies 
splicing. are presently in progress in our laboratories. 
The divergent amino-terminal region of the Ia 
and I,& form of cGK corresponds to dimerization 
and inhibitory domains. Therefore, if Ia and v 
forms of cGK are 100% similar for amino acids 
105-686, which contain the two cGMP-binding 
sites as well as the catalytic domain, then the 
dimerization and inhibitory domains must 
somehow contribute to the differences observed by 
Wolfe et al. [16,32] in cGMP and cGMP analog 
binding to types Icr and I.@. 
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In the amino-terminal part of the bovine type 
ICU, four different autophosphorylation sites 
(Ser-50, Thr-58, Ser-72 and Thr-84) are observed 
[33]. Of these amino acids, only Ser-50 is conserv- 
ed in the human type I# (fig.3). This is in accor- 
dance with the observations of Wolfe et al. [32] 
that the bovine Ia and I,& autophosphorylate at dif- 
ferent amino acid residues. They also found that 
autophosphorylation was almost exclusively on 
serine residues of bovine I,&. In the amino-terminal 
part of the human Ip cGK that has low homology 
to h, there are 6 serine residues (at positions 51, 
64, 66, 80, 92 and 102). Based upon our data, it is 
not possible to predict which of these serine 
residues can be autophosphorylated. 
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